FromSA: Key events next week - healthcare Jan.
Post# of 36566
(Total Views: 299)
Posted On: 01/17/2020 8:38:07 AM
FromSA:
Key events next week - healthcare
Jan. 17, 2020 6:49 AM ET|About: Epizyme, Inc. (EPZM)|By: Douglas W. House, SA News Editor
Noteworthy events during the week of January 19 - 25 for healthcare investors.
TUESDAY (1/21): Generex Biotechnology (OTCQB:GNBT): Investor conference call to discuss stock sales by certain institutional investors, NGIO spinout and funding.
THURSDAY (1/23): ASCO GI Cancers Symposium, San Francisco (3 days). Forty Seven (NASDAQ:FTSV): Phase 1 data on magrolimab + cetuximab in colorectal cancer. Bellicum Pharmaceuticals (NASDAQ:BLCM): Phase 1 data on BPX-601 in pancreatic cancer.
FDA action date for Epizyme's (NASDAQ:EPZM) tazemetostat for epitheloid sarcoma.
Society for Nuclear and Molecular Medicine Mid-Winter Meeting, Tampa, FL (3 days). Progenics Pharmaceuticals (NASDAQ
GNX): Use of PyL in detection of prostate cancer.
SATURDAY (1/25): Nevro (NYSE:NVRO) investor briefing at NANS Conference.
Try Seeking Alpha PREMIUM for unlimited analysis on EPZM
6,014 people have EPZM in their portfolio and get alerts
Key events next week - healthcare
Jan. 17, 2020 6:49 AM ET|About: Epizyme, Inc. (EPZM)|By: Douglas W. House, SA News Editor
Noteworthy events during the week of January 19 - 25 for healthcare investors.
TUESDAY (1/21): Generex Biotechnology (OTCQB:GNBT): Investor conference call to discuss stock sales by certain institutional investors, NGIO spinout and funding.
THURSDAY (1/23): ASCO GI Cancers Symposium, San Francisco (3 days). Forty Seven (NASDAQ:FTSV): Phase 1 data on magrolimab + cetuximab in colorectal cancer. Bellicum Pharmaceuticals (NASDAQ:BLCM): Phase 1 data on BPX-601 in pancreatic cancer.
FDA action date for Epizyme's (NASDAQ:EPZM) tazemetostat for epitheloid sarcoma.
Society for Nuclear and Molecular Medicine Mid-Winter Meeting, Tampa, FL (3 days). Progenics Pharmaceuticals (NASDAQ
GNX): Use of PyL in detection of prostate cancer. SATURDAY (1/25): Nevro (NYSE:NVRO) investor briefing at NANS Conference.
Try Seeking Alpha PREMIUM for unlimited analysis on EPZM
6,014 people have EPZM in their portfolio and get alerts
(0)
(0)